[Clinical study of a new analgesic : 3-morpholinylethoxy, 3-methyl-4 (2'naphtyl)-6-pyridazine hydrochloride or Agr. 614].
D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D000818:Animals; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008745:Methylation; D008875:Middle Aged; D009025:Morpholines / Q000009:adverse effects / Q000627:therapeutic use*; D009281:Naphthalenes / Q000009:adverse effects / Q000627:therapeutic use; D011724:Pyridazines / Q000009:adverse effects / Q000627:therapeutic use*; D011817:Rabbits
D000700:Analgesics; D009025:Morpholines; D009281:Naphthalenes; D011724:Pyridazines
Etude clinique d'un nouvel analgésique : le chlorhydrate de morpholinylethoxy-3 méthyl-4 (2'naphtyl)-6 pyridazine ou Agr. 614